China SXT Pharmaceuticals annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
China SXT Pharmaceuticals Operating Margin Growth & History (SXTC)
China SXT Pharmaceuticals's operating margin was −625.89% for fiscal 2026.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −625.89% | −471.92 pp |
| 2025 | 2025-03-31 | −153.97% | −23.55 pp |
| 2024 | 2024-03-31 | −130.42% | +153.98 pp |
| 2023 | 2023-03-31 | −284.40% | −84.97 pp |
| 2022 | 2022-03-31 | −199.43% | −153.44 pp |
| 2021 | 2021-03-31 | −45.99% | −20.01 pp |
| 2020 | 2020-03-31 | −25.98% | −51.21 pp |
| 2019 | 2019-03-31 | 25.24% | +1.98 pp |
| 2018 | 2018-03-31 | 23.25% | −9.57 pp |
| 2017 | 2017-03-31 | 32.82% | — |
China SXT Pharmaceuticals quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
China SXT Pharmaceuticals operating margin trends
Over the last five reported fiscal years, China SXT Pharmaceuticals's operating margin decreased from −45.99% to −625.89%, a change of −579.90 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China SXT Pharmaceuticals filings at SEC.gov ↗